Mu-Tong Chen
Overview
Explore the profile of Mu-Tong Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Chen M, He Y, Chen M, Liang J, Jia F, et al.
Lipids Health Dis
. 2024 Sep;
23(1):288.
PMID: 39252009
Background: High-density lipoprotein cholesterol (HDL-C) is widely recognized for its protective effects against cognitive decline. However, recent studies have presented conflicting results, with some suggesting no significant cognitive benefits or...
2.
Chen M, Li B, Zhang E, Zheng Q
Medicine (Baltimore)
. 2023 Oct;
102(40):e35086.
PMID: 37800802
During the course of treating non-small cell lung cancer (NSCLC) with epithelial growth factor receptor (EGFR) mutant, gefitinib resistance (GR) is unavoidable. As the environment for tumor cells to grow...
3.
Liang Y, Deng Z, Chen M, Qiu S, Xiao Y, Qi Y, et al.
Front Oncol
. 2021 Sep;
11:710286.
PMID: 34527583
The chemokine CXCL9 (C-X-C motif chemokine ligand 9) has been reported to be required for antitumour immune responses following immune checkpoint blockade. In this study, we sought to investigate the...
4.
Xie Q, Xiao Y, Jia S, Zheng J, Du Z, Chen Y, et al.
Cancer Cell Int
. 2020 Dec;
20(1):562.
PMID: 33292226
Background: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers...